Announcements

Announcements
 
 
BMGF – Gates Foundation  [to 1 Dec 2018]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute    [to 1 Dec 2018]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X   [to 1 Dec 2018]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 1 Dec 2018]
http://cepi.net/
No new digest content identified.
 
 
EDCTP    [to 1 Dec 2018]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
30 November 2018
World AIDS Day 2018: Supporting R&D partnerships to tackle HIV
World AIDS Day 2018 marks its 30th anniversary. Significant progress has been made in the fight against the disease during these three decades. However, the Global AIDS Update 2018
report shows that much needs to be done to reach the…
 
 
26 November 2018
National health research systems in Africa: developing a collaborative approach
EDCTP published the report on the EDCTP high-level meeting Engaging African governments to strengthen national health research systems with complementary international cooperation. The meeting took place in Dakar, Senegal, on 30 August 2018. It was organised as a side meeting…
 
 
Emory Vaccine Center    [to 1 Dec 2018]
http://www.vaccines.emory.edu/
No new digest content identified.
 
 
European Medicines Agency  [to 1 Dec 2018]
http://www.ema.europa.eu/ema/
News and press releases
No new digest content identified.
 
 
European Vaccine Initiative  [to 1 Dec 2018]
http://www.euvaccine.eu/news-events
No new digest content identified.
 
 
FDA [to 1 Dec 2018]
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
No new digest content identified.
November 28, 2018 –
FDA approves treatment for adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a certain genetic mutation
 
 
November 26, 2018 –
 FDA approves an oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor
 
 
November 26, 2018 –
Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on transformative new steps to modernize FDA’s 510(k) program to advance the review of the safety and effectiveness of medical devices
 
 
Fondation Merieux  [to 1 Dec 2018]
http://www.fondation-merieux.org/
Mérieux Foundation co-organized event
OCV working group / Global Task Force on Cholera Control (GTFCC)
December 5 – 6, 2018 – Les Pensieres Center for Global Health, Veyrier-du-Lac (France)
 
Partner event
ASLM 2018 – Preventing and controlling the next pandemic: the role of laboratory
December 10 – 13, 2018 – Abuja (Nigeria)
 
Mérieux Foundation co-organized event
Dengue pre-vaccination screening based on serostatus: rapid tests and implementation strategies
January 14 – 16, 2019 – Les Pensières Center for Global Helath, Veyrier du Lac (France)
 
 
Gavi [to 1 Dec 2018]
https://www.gavi.org/
29 November 2018
Measles cases spike globally due to gaps in vaccination coverage: New report
 
Gavi Board starts framing Alliance’s approach to 2021-2025 period
29 November 2018
[See Milestones above for detail]
 
Gavi recognised as an equal salary employer
26 November 2018
 
 
GHIT Fund   [to 1 Dec 2018]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.
 
 
Global Fund  [to 1 Dec 2018]
https://www.theglobalfund.org/en/news/
30 November 2018
Global Fund Marks World AIDS Day

Feature Story
Young Women at the Epicenter of HIV
29 November 2018

Global Fund Applauds UNAIDS Report on HIV Testing
27 November 2018
The Global Fund to Fight AIDS, Tuberculosis and Malaria welcomed a new report by UNAIDS that shows great gains in HIV testing, and getting people to know their HIV status. Knowledge is Power, the report released just prior to World AIDs Day on 1 December, shows that 75 percent of people living with HIV aware of their status in 2017, compared with 67 percent in 2015…
 
 
Hilleman Laboratories   [to 1 Dec 2018]
http://www.hillemanlabs.org/
No new digest content identified.
 
 
Human Vaccines Project   [to 1 Dec 2018]
http://www.humanvaccinesproject.org/media/press-releases/
No new digest content identified.
 
 
IAVI  [to 1 Dec 2018]
https://www.iavi.org/newsroom
November 29, 2018
IAVI Report Vol. 22, No. 3, 2018
Scientists are more optimistic than ever about developing HIV vaccines and antibody-based products.
 
IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.
 
IVAC  [to 1 Dec 2018]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
No new digest content identified.
 
 
IVI   [to 1 Dec 2018]
http://www.ivi.int/
IVI News & Announcements
BOT meets face-to-face and visits KCDC & LG Chem’s vaccine plant
On Nov. 19, 2018, IVI’s Board of Trustees convened at IVI headquarters in Seoul for their second face-to-face meeting of the year. This was followed by a visit to the Korea Center for Disease Control (KCDC) on Nov. 20 to exchange information on new initiatives, discuss matters of mutual interest, and to explore opportunities to further expand their partnership, as well as a site tour to LG Chem’s vaccine plant in Osong, North Chungcheong Province…
 
Scientific Advisory Group (SAG) gathers for 17th meeting
IVI’s Scientific Advisory Group (SAG) convened at IVI headquarters in Seoul on November 15 for their 17th annual two-day-long meeting. This event brings together IVI scientists and members of the SAG. The SAG consists of 16 members, including distinguished vaccinologists and public health leaders, who have been helping the Institute to chart the direction of vaccine research and development, and to explore future opportunities. During this meeting they shared an overview of the latest in IVI projects and exchanged new information and ideas…
 
 
JEE Alliance  [to 1 Dec 2018]
https://www.jeealliance.org/
No new digest content identified.
 
 
MSF/Médecins Sans Frontières  [to 1 Dec 2018]
http://www.msf.org/
Selected News; Project Updates, Reports
World AIDS Day
UNAIDS report overlooks significant aspects of the global HIV response
Statement 29 Nov 2018
UNAIDS’ World AIDS Day 2018 report is selectively silent on persistently high AIDS mortality and looming treatment rationing in light of donor disengagement.
This year’s UNAIDS report highlights the importance of viral load testing, a critical indicator of the effectiveness of HIV treatment in people living with HIV.
Yet the focus on HIV testing and regular viral load monitoring overlooks fundamental aspects of today’s HIV epidemic and continued high numbers of AIDS-related deaths.
The report also fails to profile the significant shortfalls in international support to effectively fight the HIV/AIDS epidemic…

HIV/AIDS
Pharmaceutical corporations are failing children with HIV
Press Release 29 Nov 2018
:: Kids living with HIV need to be on antiretroviral (ARV) treatment for life to stay healthy
:: One year ago, pharmaceutical corporations committed to improving access to paediatric versions of HIV drugs for children, but very little progress has been made
:: MSF urges pharmaceutical corporations including Viiv and Merck to immediately register paediatric ARVs and improve access for kids.
 
 
NIH  [to 1 Dec 2018]
http://www.nih.gov/news-events/news-releases
November 30, 2018
NIH Statement on World AIDS Day December 1, 2018
— We now have life-saving antiretroviral drugs to treat and greatly extend the lives of men and women living with HIV.

November 27, 2018
Clinical trial of investigational Ebola treatments begins in the Democratic Republic of the Congo
— Study is enrolling patients of any age with confirmed Ebola virus disease.
[See Milestones above for detail]
 
 
PATH  [to 1 Dec 2018]
https://www.path.org/media-center/
Nov. 30, 2018
Vietnam launches national program for pre-exposure prophylaxis for HIV
PATH, USAID, and Vietnam’s Ministry of Health launch PrEP program to substantially reduce new HIV infections as total PrEP service enrollment passes 2,000.
 
 
Sabin Vaccine Institute  [to 1 Dec 2018]
http://www.sabin.org/updates/pressreleases
No new digest content identified.
 
 
UNAIDS [to 1 Dec 2018]
http://www.unaids.org/en
27 November 2018
Call for minimum standards of PrEP provision and monitoring in Europe

26 November 2018
Countries in eastern Europe and central Asia agree to expand access to a range of medicines
 
 
UNICEF  [to 1 Dec 2018]
https://www.unicef.org/media/press-releases
Selected Press Releases/Reports/Statements
Press release
Around 80 adolescents will die of AIDS every day by 2030, at current trends – UNICEF
UNICEF calls for urgent scale-up of treatment and prevention programmes among adolescents as data shows slow reduction of HIV infections and AIDS-related deaths
29/11/2018
 
 
Press release
2018 Global Nutrition Report reveals malnutrition is unacceptably high and affects every country in the world, but there is also an unprecedented opportunity to end it.
28/11/2018
 
 
Press release
Measles cases spike globally due to gaps in vaccination coverage: New report
29/11/2018
[See Milestones above for detail]
 
 
Press release
UNICEF strengthens support for women and children in Venezuela
Supplies for 350,000 women and children flown in since August
…Working with the Ministry of Health, UNICEF has also provided 30 tons of medicines and health supplies to help stop the spread of infectious diseases and to improve health outcomes for children and women in vulnerable communities. These supplies will be used in the treatment and care for 25,000 pregnant women, 10,000 newborns in neonatal wards and more than 2,300 children living with HIV. Through UNICEF’s expanded programme, 40,000 pregnant women now have access to rapid HIV and syphilis tests, while 100,000 children and pregnant women have access to malaria treatment.
UNICEF, present in Venezuela since 1991, has over the past two years strengthened its work with partners to provide vulnerable children affected by the economic crisis with support in education, health, nutrition and protection. So far this year, UNICEF has also supported the vaccination of children with 2.5 million doses of measles vaccines and provided antiretrovirals for 2,334 children and antimalarial treatment for 150,000 children.
 
 
Vaccine Confidence Project  [to 1 Dec 2018]
http://www.vaccineconfidence.org/
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 1 Dec 2018]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.
 
 
Wellcome Trust  [to 1 Dec 2018]
https://wellcome.ac.uk/news
29 November 2018
How should Wellcome best support science to achieve our mission of improving health?
We’re launching a review of how Wellcome supports science. Jeremy Farrar explains why it’s necessary and what we hope to achieve.
Wellcome’s mission is to improve health for everyone by helping great ideas to thrive. We achieve this in large part through our support for science, where we spend almost £630 million a year through many different mechanisms. But while the way we support science has varied little over several decades, science and the way it is done have changed.
With this in mind, it is timely for Wellcome to review the way we support research to ensure we get the best possible advances in scientific knowledge and health. How do we know, as technologies and ways of working change, that our current approach is the right one?
To answer these questions, we have decided to review how Wellcome supports science. Director of Science Jim Smith will lead a small group that will explore questions such as:
:: What disciplines and areas of science should Wellcome support?
:: What career stages should Wellcome focus on?
:: Where should Wellcome fund?
:: With whom should Wellcome partner?…
 
 
The Wistar Institute   [to 1 Dec 2018]
https://www.wistar.org/news/press-releases
No new digest content identified.
 
 
World Organisation for Animal Health (OIE)   [to 1 Dec 2018]
http://www.oie.int/en/for-the-media/press-releases/2018/
No new digest content identified.

::::::

BIO    [to 1 Dec 2018]
https://www.bio.org/insights/press-release
Nov 30 2018
BIO Commends Signing of the United States-Mexico-Canada Agreement
Washington, D.C. (November 30, 2018) – Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada…
 
 
BIO Statement on Unsubstantiated Reports of Heritable Human Genome Editing Experiments in China
Nov 28 2018
The Biotechnology Innovation Organization (BIO) issued the following statement regarding unsubstantiated reports this week of experiments involving heritable human genome editing in China.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 1 Dec 2018]
http://www.dcvmn.org/
No new digest content identified.
 
 
IFPMA   [to 1 Dec 2018]
http://www.ifpma.org/resources/news-releases/
No new digest content identified.
 
 
PhRMA    [to 1 Dec 2018]
http://www.phrma.org/press-room
Latest News
PhRMA Statement on Signing the U.S.-Mexico-Canada Agreement (USMCA)
WASHINGTON, D.C. (November 30, 2018) – Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement:
“We congratulate the United States, Mexico and Canada on signing the U.S.-Mexico-Canada Agreement (USMCA). This is an important step in the process to modernize North American trade, including by improving critical intellectual property (IP) protections and other standards in Canada and Mexico that will help to usher in the next generation of medical treatments and cures. When countries protect and value innovation, America’s biopharmaceutical companies can continue bringing new medicines to patients around the world. The IP standards in the USMCA far exceed those in any other international trade agreement. We look forward to continuing to assist efforts by the Administration and Congress to pass the USMCA.”…